Search filters

List of works by Valentina Guarneri

18F-Fluoroestradiol Positron Emission Tomography in Breast Cancer Patients: Systematic Review of the Literature & Meta-Analysis.

scientific article

Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy.

scientific article published on March 2004

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis

scientific article

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project

article

Androgen Receptor Expression and Association With Distant Disease-Free Survival in Triple Negative Breast Cancer: Analysis of 263 Patients Treated With Standard Therapy for Stage I-III Disease.

scientific article published on 6 June 2019

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer

scientific article published on 01 March 2019

BMI is an independent prognostic factor for late outcome in patients diagnosed with early breast cancer: A landmark survival analysis

scientific article published on 20 July 2019

Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome

scientific article published on 16 November 2016

Biomarkers predicting clinical benefit: fact or fiction?

scientific article published on 01 January 2011

Blurring of boundaries in the doctor-patient relationship.

scientific article published on 24 November 2014

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

scientific article published on April 2006

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO).

scientific article

Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?

scientific article

Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations

scientific article

Clinical utility of measuring circulating tumor cells in metastatic breast cancer

scientific article published on 01 April 2006

Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology

scientific article published on 17 August 2018

Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management

scientific article published on 23 July 2008

Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: results for the Gruppo Oncologico Nord Ovest randomized trial.

scientific article

Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment?

scientific article

Detection of microparticles from human red blood cells by multiparametric flow cytometry.

scientific article

Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients.

scientific article published on 13 April 2017

Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancer

scientific article published on 01 October 2006

Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer ⬇️

scientific article published on January 21, 2012

Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials

scientific article published on 3 April 2017

Escalation and de-escalation in HER2 positive early breast cancer

scientific article published on 01 January 2019

Exceptional and Durable Responses to TDM-1 After Trastuzumab Failure for Breast Cancer Skin Metastases: Potential Implications of an Immunological Sanctuary

article

External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience

scientific article

Fat grafting for breast cancer patients: From basic science to clinical studies

scientific article

First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer

scientific article

From Diagnostic-Therapeutic Pathways to Real-World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR-Positive Non-Small Cell Lung Cancer (MOST Study)

scientific article published on 07 March 2019

GD2 expression in breast cancer.

scientific article

Gastric Linitis Plastica and Peritoneal Carcinomatosis as First Manifestations of Occult Breast Carcinoma: A Case Report and Literature Review

scientific article published on 08 July 2018

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

scientific article published on 01 January 2020

High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC).

scientific article published in January 2001

Histology-based Combination Induction Chemotherapy for Elderly Patients with Clinical Stage III Non-small Cell Lung Cancer

scientific article published in July 2017

Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer

scientific article published on 27 February 2018

Immune characterization of breast cancer metastases: prognostic implications.

scientific article

Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer.

scientific article published on 5 July 2016

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges

scientific article published on 05 August 2019

Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study

scientific article published on 31 May 2019

Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials

scientific article

Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial

scientific article

Interaction of host immunity with HER2-targeted treatment and tumor heterogeneity in HER2-positive breast cancer

scientific article published on 29 March 2019

Lapatinib plus letrozole for postmenopausal patients with advanced HER2(+)/HR(+) breast cancer.

scientific article

Letrozole versus letrozole plus Lapatinib (GW572016) in hormone-sensitive, HER2-negative operable breast cancer: a double-blind, randomized, phase II study with biomarker evaluation (EGF109077-LAP107692/LETLOB).

scientific article published in February 2008

Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the M.D. Anderson Cancer Center experience

scientific article published on 14 August 2006

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients.

scientific article

Magnetic resonance imaging and ultrasonography in predicting infiltrating residual disease after preoperative chemotherapy in stage II-III breast cancer

scientific article published on 8 February 2011

Maintenance therapy in epithelial ovarian cancer: from chemotherapy to targeted agents

scientific article

Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas

scientific article

Neoplastic Pericardial Effusion: A Monocentric Retrospective Study

scientific article published on 19 March 2019

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡

scientific article published on 01 December 2018

Olaparib for the treatment of breast cancer

scientific article published on 30 March 2018

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab

scientific article published on 01 October 2018

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab

scientific article published on 01 July 2019

PIK3CA mutations are associated with reduced pathological complete response rates in primary HER2-positive breast cancer: pooled analysis of 967 patients from five prospective trials investigating lapatinib and trastuzumab.

scientific article

PIK3CA: a Target or a Marker in Breast Cancers

Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer Center

scientific article published on 02 July 2018

Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors

scientific article published on 23 April 2019

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

scientific article published on 02 July 2007

Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancer

scientific article published on 09 August 2007

Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2- Breast Cancer

scientific article published on 15 October 2019

Predictive value of biologic parameters for primary chemotherapy in operable breast cancer.

scientific article

Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis

scientific article published on 03 March 2012

Preoperative Carboplatin–Paclitaxel–Bevacizumab in Triple-Negative Breast Cancer: Final Results of the Phase II Ca.Pa.Be Study

scientific article published on 09 January 2015

Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey.

scientific article published on 25 April 2017

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

scientific article published on 20 May 2015

Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation

scientific article published on 16 June 2017

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

scientific article published in March 2006

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

scientific article published on 08 January 2014

Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study

scientific article published on July 2015

Programmed Cell Death Ligand 1 in Breast Cancer: Technical Aspects, Prognostic Implications, and Predictive Value

scientific article published on 23 August 2019

Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma.

scientific article published on July 2005

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer

scientific article

Rare breast cancer subtypes: histological, molecular, and clinical peculiarities

scientific article

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients

scientific article

Relapsed Triple-Negative Breast Cancer: Challenges and Treatment Strategies ⬇️

scientific article published on August 1, 2013

Renal safety and efficacy of i.v. bisphosphonates in patients with skeletal metastases treated for up to 10 Years.

scientific article published in November 2005

SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab

scientific article published on 31 March 2017

Targeting the right chemotherapy for the right patient

The Future of Chemotherapy in the Era of Personalized Medicine

The Next Generation of Biologic Agents: Therapeutic Role in Relation to Existing Therapies in Metastatic Breast Cancer ⬇️

scientific article published on June 1, 2012

The clinical relevance of endocrine-therapy-induced changes in lipid metabolism in breast cancer patients.

scientific article published on 5 August 2009

The immune system and hormone-receptor positive breast cancer: Is it really a dead end?

scientific article published on 28 March 2016

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

scientific article published on 01 August 2018

Therapeutic perspectives for brain metastases in non-oncogene addicted non-small cell lung cancer (NSCLC): Towards a less dismal future?

scientific article published on 24 May 2018

Timing for starting second-line therapy in recurrent ovarian cancer

scientific article published on January 2011

Trastuzumab-containing regimens for metastatic breast cancer

scientific article

Tumor Stroma Manipulation By MSC.

scientific article published on 7 March 2016

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.

scientific article published on 13 March 2017

Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers ⬇️

scientific article published on May 28, 2011

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.

scientific article published on 16 March 2014

Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study

scientific article published on 14 December 2019

Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial

scientific article published on 21 November 2019

Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.

scientific article published in December 2002

Whole exome sequencing of rare aggressive breast cancer histologies.

scientific article

Paulina is supported by:

About Paulina

Help